Advantages of Foxp3<sup>+</sup>regulatory T cell depletion using DEREG mice

Christian T. Mayer(Helmholtz Centre for Infection Research), Katharina Lahl(VA Palo Alto Health Care System), Pedro Milanez‐Almeida(Helmholtz Centre for Infection Research), Deepika Watts(Technische Universität Dresden), Ulf Dittmer(University of Duisburg-Essen), Nanna Fyhrquist(Finnish Institute of Occupational Health), Jochen Huehn(Helmholtz Centre for Infection Research), Manfred Köpf, Karsten Kretschmer(Deutsches Diabetes-Zentrum e.V.), Barry T. Rouse(University of Tennessee at Knoxville), Tim Sparwasser(Helmholtz Centre for Infection Research)
Immunity Inflammation and Disease
October 26, 2014
Cited by 36Open Access
Full Text

Abstract

Several mechanisms enable immunological self-tolerance. Regulatory T cells (Tregs) are a specialized T cell subset that prevents autoimmunity and excessive immune responses, but can also mediate detrimental tolerance to tumors and pathogens in a Foxp3-dependent manner. Genetic tools exploiting the foxp3 locus including bacterial artificial chromosome (BAC)-transgenic DEREG mice have provided essential information on Treg biology and the potential therapeutic modulation of tolerance. In DEREG mice, Foxp3(+) Tregs selectively express eGFP and diphtheria toxin (DT) receptor, allowing for the specific depletion of Tregs through DT administration. We here provide a detailed overview about important considerations such as DT toxicity, which affects any mouse strain treated with DT, and Treg rebound after depletion. Additionally, we point out the specific advantages of BAC-transgenic DEREG mice including their suitability to study organ-specific autoimmunity such as type I diabetes. Moreover, we discuss recent insights into the role of Tregs in viral infections. In summary, DEREG mice are an important tool to study Treg-mediated tolerance and its therapeutic circumvention.


Related Papers

No related papers found

Powered by citation graph analysis